Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
04/11/2002 | WO2001096877A3 Rare earth metal cryptates showing reduced fluorescence quenching |
04/11/2002 | US20020042523 Reacting an amino-protected aspartic anhydride with an aralkylamine, cyclodehydration to obtain a 1-aralkyl-3-(protected amino)pyrrolidine-2,5-dione, reducing carbonyl groups, then hydrogenolysis; carbapenems, drug intermediate |
04/11/2002 | US20020042427 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
04/11/2002 | US20020042426 Novel basic derivatives of benz[e] isoindol-1-ones and pyrrolo[3,4-c] quinolin-1ones with 5-HT3-antagonistic activity, their preparation and their therapeutic use |
04/11/2002 | US20020042420 Alzheimer's diseas, Parkinson disease, Huntington disease |
04/11/2002 | US20020042419 Administering growth hormone secretagogue |
04/11/2002 | US20020042415 Dipeptide derivatives |
04/11/2002 | US20020042414 Antiallergens |
04/11/2002 | US20020042412 Fused azepinone cyclin dependent kinase inhibitors |
04/11/2002 | US20020041887 Immune response modifier compounds for treatment of TH2 mediated and related diseases |
04/11/2002 | CA2424304A1 Process for preparation of integrin receptor antagonist intermediates |
04/11/2002 | CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
04/11/2002 | CA2424222A1 Inhibitors of prenyl-protein transferase |
04/11/2002 | CA2424117A1 Phosphoric acid salt of an integrin receptor antagonist |
04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
04/11/2002 | CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists |
04/10/2002 | EP1195378A1 Pyridotriazines and pyridopyridazines |
04/10/2002 | EP1195372A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity |
04/10/2002 | EP1194425A1 Substituted benzimidazole |
04/10/2002 | EP1194151A1 Integrin receptor antagonists |
04/10/2002 | EP1042323B1 Novel camptothecin tetracyclic analogues, preparation, methods, applications as medicines and pharmaceutical compositions containing them |
04/10/2002 | EP0918774B9 Androgen receptor modulator compounds and methods |
04/10/2002 | EP0912567B1 Carboline derivatives |
04/10/2002 | EP0739351B1 Monomeric diols and phosphate linked oligomers formed therefrom |
04/10/2002 | EP0712402B1 Hydroisoquinoline derivatives |
04/10/2002 | CN1344269A Pharmaceutical compsn. based on polyaromatic compounds |
04/10/2002 | CN1344268A Use of imidazo [1,5-a]pyrido[3,2-e]-pyrazinones as medicaments |
04/10/2002 | CN1344266A Novel compounds |
04/10/2002 | CN1344257A Fused pydiopyridazine inhibitors of cGMP phosphodiesterase |
04/10/2002 | CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors |
04/10/2002 | CN1082509C Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents |
04/09/2002 | USRE37650 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase |
04/09/2002 | US6369227 Thrombin or factor Xa inhibitors |
04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
04/09/2002 | US6369072 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
04/09/2002 | US6369059 Tetracyclic derivatives, process of preparation and use |
04/09/2002 | US6369002 Hetero is pyrimidine or pyridazine; 1-(3-fluoro-5-chloro pyridin-2-yl)-3-methyl-4-trifluoromethylpyrimidin-2,6-dione |
04/09/2002 | CA2120229C Methylpiperazinoazepine derivatives, their preparation and their use |
04/09/2002 | CA2095338C Individual stereoisomers of 7-¬3-(aminoalkyl)-1-pyrrolidinyl|-quinolonesand naphthyridones as antibacterial agents |
04/04/2002 | WO2002026891A1 Modified carbocyanine dyes and their conjugates |
04/04/2002 | WO2002026743A1 Novel pyridazine compounds for the treatment of diabetes |
04/04/2002 | WO2002026741A1 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN |
04/04/2002 | WO2002026740A1 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain |
04/04/2002 | WO2002026739A1 1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
04/04/2002 | WO2002026738A1 1,2,5,10-TETRAHYDROPYRIDAZINO[4,5-b]QUINOLINE-1,10-DIONES AND THEIR USE FOR THE TREATMENT OF PAIN |
04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
04/04/2002 | WO2002026220A2 Taxoid conjugates as antimitotic and antitumor agents |
04/04/2002 | WO2001094347A8 Tetracyclic diketopiperazine compounds as pdev inhibitors |
04/04/2002 | WO2001085694A3 Substituted diamide derivatives useful as motilin antagonists |
04/04/2002 | WO2001074815A3 Phenyl-substituted imidazopyridines |
04/04/2002 | WO2001074810A3 Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists |
04/04/2002 | WO2001074773A3 Phenyl-substituted indoles as histamine h3-receptor antagonists |
04/04/2002 | WO2001047898A3 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp) |
04/04/2002 | US20020040147 Novel catechols as antimicrobial agents |
04/04/2002 | US20020040030 Derivatives of 3-(pyrimidin-5- yl)- and 3-(2-methyl-pyrimidin-5-yl)-9-(5,6,7,8-tetrahydro(1,8) naphthyridin-2-yl)-nonanoic acid useful for inhibiting bone resorptin, restenosis, angiogenesis, diabetic retinopathy etc |
04/04/2002 | US20020040028 2-amine substituted quinoline or quinozoline derivatives useful for treating benign prostatic hyperplasia |
04/04/2002 | US20020040024 A phenoxy substituted piperidine derivative, useful for treating or preventing histamine H3 receptor activity |
04/04/2002 | US20020040020 Substituted pyrazoles |
04/04/2002 | US20020040019 Substituted pyrazoles |
04/04/2002 | CA2423483A1 Taxoid conjugates as antimitotic and antitumor agents |
04/04/2002 | CA2423305A1 Compounds useful in the treatment of inflammatory diseases |
04/03/2002 | EP1192165A2 Substituted heterocycle fused gamma-carbolines |
04/03/2002 | EP1192160A1 1-azatricyclic-4-benzylpiperazines |
04/03/2002 | EP1192157A1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
04/03/2002 | EP1192156A1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
04/03/2002 | EP1192155A1 New bispidine compounds useful in the treatment of cardiac arrhythmias |
04/03/2002 | EP1192154A1 Bispidine compounds useful in the treatment of cardiac arrhythmias |
04/03/2002 | EP1192153A2 Method for the enantiomer separation of cis-8-benzyl-7,9-dioxo-2,8-diazabicyclo 4.3.0]nonane |
04/03/2002 | EP1192151A1 Anilinoquinazolines as protein tyrosine kinase inhibitors |
04/03/2002 | EP1192150A1 New pharmaceutically active compounds |
04/03/2002 | EP1192133A1 N-cyclopentyl modulators of chemokine receptor activity |
04/03/2002 | EP1161240A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP1158980A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP1156807A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP1140087A4 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
04/03/2002 | EP0929552B1 Acridone derivatives and method of preparation of 8-hydroxy imidazoacridinone derivatives |
04/02/2002 | US6365743 Process for the preparation of enantiomerically pure imidazolyl compounds |
04/02/2002 | US6365615 Dichlorophenyl tetrahydropyrrolo(1,2-c)imidazole-1,3-diones; immune cell mediated conditions; antagonists of the binding of humon intercellular adhesion molecules |
04/02/2002 | US6365599 For therapy of benign prostatic hyperplasia |
04/02/2002 | US6365598 Pyrroloquinolines for treatment of obesity |
04/02/2002 | US6365594 As opioid agonists and antagonists and are useful as i.a. analgesics |
04/02/2002 | US6365589 Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists |
04/02/2002 | US6365587 Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
04/02/2002 | US6365586 Compounds, their preparation and use |
04/02/2002 | US6365195 Fungicidal active compound combinations |
04/02/2002 | CA2053340C Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
04/02/2002 | CA2051012C Carbocyclic adenosine analogs useful as immunosupressants |
03/28/2002 | WO2002024703A1 Bicyclic heteroaromatic compounds |
03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
03/28/2002 | WO2002024699A1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof |
03/28/2002 | WO2002024697A1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
03/28/2002 | WO2002024696A1 Process for producing tricyclic fused heterocyclic derivative |
03/28/2002 | WO2002024695A2 Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines |
03/28/2002 | WO2002024694A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
03/28/2002 | WO2002024693A1 A process for producing 3,4-dihydro naphthyridinone analogs |
03/28/2002 | WO2002024687A1 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives |
03/28/2002 | WO2002024686A2 Farnesyl transferase inhibiting 6-heterocyclylmethyl quinoline and quinazoline derivatives |
03/28/2002 | WO2002024685A1 Indole derivatives and their use as antifungal and/or antiparasitic agents |
03/28/2002 | WO2002024684A1 Quinoline derivatives as antibacterials |
03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |